Open Book Extracts

Activities: Ingredients

Trending Articles

  1. Less protein may support longevity, major review finds A review of 350+ studies suggests lower protein intake could aid healthy ageing, raising questions for protein manufacturers and longevity brands as the number of fortified...
  2. FDA colour additive revocations coincide with WHO scrutiny of food ingredients The US FDA's latest action on chemicals used in food colour production comes as the WHO proposes a broader approach to assessing food formulations, potentially increasing...
  3. Triphala: a traditional three-fruit approach to gut health Probiotics started Europe's gut health conversation. What comes next may be a centuries-old Ayurvedic recipe of just three fruits. Discover the story behind Triphala, why its...
  4. Independent testing finds six of twelve top-selling Amazon glutathione supplements fail label claims Cata-Kor's commissioned HPLC analysis, conducted by ISO 17025-accredited Swift Laboratory, found glutathione content ranging from undetectable to significantly under-labelled...
  5. How IMA tackles the challenge of non-compressible nutraceutical powders Discover how vacuum dosing technology and mechanical optimisations enable reliable capsule filling with pure natural powders, without the need for excipients

Upcoming event

Food Ingredients Europe

17-19 November 2026 | Messe Frankfurt See all

Related Content

Ingredients
Open Book Extracts (OBX) announces founding membership in ONE HEMP

Open Book Extracts (OBX) announces founding membership in ONE HEMP

Since the inception of Open Book Extracts (OBX) in 2019, the company has served as a leader in the hemp-based CBD market, prioritising science, safety, and responsible commerce
Ingredients
OBX launches trial for minor cannabinoid formulations

OBX launches trial for minor cannabinoid formulations

The cannabinoids selected were CBD, CBG, CBC, and CBDV, and the polyphenols selected were Quercetin and Curcumin
Finance
OBX receives strategic investment from Btomorrow Ventures

OBX receives strategic investment from Btomorrow Ventures

The two companies have signed a scientific collaboration agreement covering areas of future R&D
Ingredients
Open Book Extracts expands capabilities and management team to boost finished goods manufacturing

Open Book Extracts expands capabilities and management team to boost finished goods manufacturing

The expansion will serve to address increased demand for the company’s product development and manufacturing services
Regulatory
OBX announces results of Phase I toxicology assessment

OBX announces results of Phase I toxicology assessment

The company contracted AIBMR Life Sciences to conduct the studies investigating the safety of consuming its CBG, CBN, and CBC products
Ingredients
OBX completes trial of cannabinoids for pain relief

OBX completes trial of cannabinoids for pain relief

Results from the pain study are expected in late April 2022 and will be announced at that time
Ingredients
Open Book Extracts appoints European sales leadership

Open Book Extracts appoints European sales leadership

In March 2021, OBX became a member of the European Industrial Hemp Association Novel Food Consortium
Subscribe now